124 related articles for article (PubMed ID: 9875430)
1. Synthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent.
Cheon SH; Park JS; Chung BH; Choi BG; Cho WJ; Choi SU; Lee CO
Arch Pharm Res; 1998 Apr; 21(2):193-7. PubMed ID: 9875430
[TBL] [Abstract][Full Text] [Related]
2. Studies on the synthesis and in vitro antitumor activity of the isoquinolone derivatives.
Cheon SH; Lee JY; Chung BH; Choi BG; Cho WJ; Kim TS
Arch Pharm Res; 1999 Apr; 22(2):179-83. PubMed ID: 10230509
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of isoquinolinone type anticancer agent.
Cheon SH; Park JS; Lee JY; Lee YN; Yi H; Chung BH; Choi BG; Cho WJ; Choi SU; Lee CO
Arch Pharm Res; 2001 Aug; 24(4):276-80. PubMed ID: 11534756
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents.
Cho WJ; Park MJ; Chung BH; Lee CO
Bioorg Med Chem Lett; 1998 Jan; 8(1):41-6. PubMed ID: 9871625
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.
Houlihan WJ; Munder PG; Handley DA; Cheon SH; Parrino VA
J Med Chem; 1995 Jan; 38(2):234-40. PubMed ID: 7830265
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship studies of 2,3-dihydroimidazo[2,1-a]isoquinoline analogs as antitumor agents.
Cheon SH; Park JS; Jeong SH; Chung BH; Choi BG; Cho WJ; Kang BH; Lee CO
Arch Pharm Res; 1997 Apr; 20(2):138-43. PubMed ID: 18975191
[TBL] [Abstract][Full Text] [Related]
7. A novel synthesis of benzo[c]phenanthridine skeleton and biological evaluation of isoquinoline derivatives.
Cho WJ; Park MJ; Imanishi T; Chung BH
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):900-2. PubMed ID: 10399841
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).
Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S
J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5,6-dihydropyrrolo[2,1-a]isoquinolines featuring an intramolecular radical-oxidative cyclization of polysubstituted pyrroles, and evaluation of their cytotoxic activity.
Reyes-Gutiérrez PE; Camacho JR; Ramírez-Apan MT; Osornio YM; Martínez R
Org Biomol Chem; 2010 Oct; 8(19):4374-82. PubMed ID: 20672155
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
Tsou HR; Liu X; Birnberg G; Kaplan J; Otteng M; Tran T; Kutterer K; Tang Z; Suayan R; Zask A; Ravi M; Bretz A; Grillo M; McGinnis JP; Rabindran SK; Ayral-Kaloustian S; Mansour TS
J Med Chem; 2009 Apr; 52(8):2289-310. PubMed ID: 19317452
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and testing of an isoquinoline-3-carboxylic-based novel anti-tumor lead.
Gao F; Liu H; Li L; Guo J; Wang Y; Zhao M; Peng S
Bioorg Med Chem Lett; 2015 Oct; 25(20):4434-6. PubMed ID: 26386603
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines.
Bermejo A; Andreu I; Suvire F; Léonce S; Caignard DH; Renard P; Pierré A; Enriz RD; Cortes D; Cabedo N
J Med Chem; 2002 Nov; 45(23):5058-68. PubMed ID: 12408717
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C).
Koneru PB; Lien EJ; Avramis VI
Pharm Res; 1993 Apr; 10(4):515-20. PubMed ID: 8483833
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.
Cushman M; Jayaraman M; Vroman JA; Fukunaga AK; Fox BM; Kohlhagen G; Strumberg D; Pommier Y
J Med Chem; 2000 Oct; 43(20):3688-98. PubMed ID: 11020283
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, cytotoxicities and DNA cleavage activities of dibenzoxepine and isoquinoline derivatives starting from dehydroabietylamine.
Liu CX; Lin ZX; Zhou AM
J Asian Nat Prod Res; 2016 Dec; 18(12):1169-1177. PubMed ID: 27696913
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
20. Discovery of N-substituted 3-arylisoquinolone derivatives as antitumor agents originating from O-substituted 3-arylisoquinolines via [2,3] or [3,3] rearrangement.
Li B; Wang G; Xu Z; Zhang Y; Huang X; Zeng B; Chen K; Shi J; Wang H; Zhu W
Eur J Med Chem; 2014 Apr; 77():204-10. PubMed ID: 24637214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
